Tuesday , September 18 2018
Home / Conditions (page 80)



Type 2 Diabetes Control with GLP-1 Agonist and Basal Insulin Combination

Glucose regulation and weight management are very important factors when treating type 2 diabetes patients… Prior studies have shown that glucagon-like peptide receptor agonist are beneficial not only for better glucose control but also helpful in weight reduction in patients with type 2 diabetes. Other studies and recommendations on type …

Read More »

Maternal Glycemia Linked to Childhood Obesity

Maternal obesity and Hispanic ethnicity were found to be most associated with childhood obesity and metabolic dysfunction…. A secondary analysis of a mild gestational diabetes mellitus treatment trial long-term follow-up study looked at the relationship between maternal oral glucose tolerance testing and childhood body mass index, fasting glucose, insulin and …

Read More »

Eye Scan Predicts Peripheral Neuropathy in Type 1 Diabetes

Corneal confocal microscopy (CCM) can predict incipient peripheral neuropathy in patients with type 1 diabetes… The technique involves the examination of unmyelinated nerve fibers at high magnification using a laser-scanning corneal confocal microscope to image the subbasal nerve plexus of the patient’s cornea. Increased severity of diabetic peripheral neuropathy is …

Read More »

Glargine vs. Liraglutide in Poorly Controlled Type 2 Diabetes Treatment

Both medications lowered HbA1c and both groups of patients lost weight…. This randomized, multinational, open-label trial included subjects treated for T2DM with metformin ± sulphonylurea, who had glycated haemoglobin (HbA1c) levels of 7.5–12%. Subjects were assigned to 24 weeks of insulin glargine, titrated to target fasting plasma glucose of 4.0–5.5 mmol/L or liraglutide, escalated …

Read More »